The deficiency of 5-methylcytosine (5mC) and its ramification in the occurrence and prognosis of colon cancer.

The incidence and mortality of colon cancer are increasing, and effective biomarkers for its diagnosis are limited. 5-methylcytosine (5mC), a vital DNA methylation marker, plays important roles in gene expression, genomic imprinting, and transposon inhibition. This study aimed to identify the predictors of colon cancer prognosis and lay the foundation for research on therapeutic targets by detecting the levels of 5mC, 5-hydroxymethylcytosine (5hmC), 5-formyl cytosine (5fC), and 5-carboxylcytosine (5caC) in colon cancer and adjacent non-tumor tissues. A tissue microarray including 100 colon cancer tissue samples and 60 adjacent non-tumor tissue samples was used. The expression levels of 5mC and its ramifications were assessed by immunohistochemistry. According to the expression levels, patients were divided into moderately positive and strongly positive groups, and the correlation between clinicopathological characteristics and methylation marks was assessed using 2-sided chi-square tests. The prognostic values of 5mC, 5hmC, 5fC, and 5caC were tested using Kaplan-Meier analyses. Compared with adjacent non-tumor tissues, the overall levels of DNA methylation were lower in colon carcinoma lesions. However, the clinical parameters were not significantly associated with these methylation markers, except for 5hmC, which was associated with the age of cancer patients (P value = .043). Kaplan-Meier analysis disclosed that moderate positive group had a significantly shorter disease specific survival than strong positive group for patients with different levels of 5mC (65.2 vs 95.2 months, P = .014) and 5hmC (71.2 vs 97.5 months, P = .045). 5mC and its ramifications (5hmC, 5fC, and 5caC) can serve as biomarkers for colon cancer. 5mC and 5hmC are stable predictors and therapeutic targets in colon cancer. However, further understanding of its function will help to reveal the complex tumorigenic process and identify new therapeutic strategies.

[1]  K. Ciombor,et al.  Diagnosis and Management of Rectal Cancer in Patients Younger Than 50 Years: Rising Global Incidence and Unique Challenges. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  R. Zheng,et al.  Cancer incidence and mortality in China, 2016 , 2022, Journal of the National Cancer Center.

[3]  Bingjie Wang,et al.  Loss of 5-hydroxymethylcytosine as a Poor Prognostic Factor for Primary Testicular Diffuse Large B-cell Lymphoma , 2022, International journal of medical sciences.

[4]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[5]  M. Nakanishi,et al.  Navigating the DNA methylation landscape of cancer. , 2021, Trends in genetics : TIG.

[6]  Wanqing Chen,et al.  Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 , 2021, Chinese medical journal.

[7]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[8]  A. Angius,et al.  Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome , 2021, International journal of molecular sciences.

[9]  M. Gönen,et al.  Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 Patients , 2020, Annals of Surgical Oncology.

[10]  H. Yagi,et al.  Downregulation of 5-hydroxymethylcytosine is associated with the progression of cervical intraepithelial neoplasia , 2020, PloS one.

[11]  Tianmin Xu,et al.  Hydroxymethylation and tumors: can 5-hydroxymethylation be used as a marker for tumor diagnosis and treatment? , 2020, Human Genomics.

[12]  G. Masika,et al.  Visual art therapy as a treatment option for cognitive decline among older adults. A systematic review and meta-analysis. , 2020, Journal of advanced nursing.

[13]  A. Goel,et al.  Epigenetics of colorectal cancer: biomarker and therapeutic potential , 2020, Nature Reviews Gastroenterology & Hepatology.

[14]  C. Stirzaker,et al.  The DNA methylation landscape in cancer , 2019, Essays in biochemistry.

[15]  Young Kee Shin,et al.  Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview , 2018, Cellular Physiology and Biochemistry.

[16]  Yun Lu,et al.  HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway , 2018, Journal of cellular biochemistry.

[17]  Y. Zhang,et al.  Genome-wide analyses reveal a role of Polycomb in promoting hypomethylation of DNA methylation valleys , 2018, Genome Biology.

[18]  Rong-Bin Liu,et al.  Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection , 2018, World journal of gastrointestinal oncology.

[19]  Jun Zhang,et al.  5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers , 2017, Cell Research.

[20]  H. Jin,et al.  DNA Methylation as a Noninvasive Epigenetic Biomarker for the Detection of Cancer , 2017, Disease markers.

[21]  S. Samiullah,et al.  Colon Cancer Screening - Is It Time Yet? , 2017, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[22]  Yi Zhang,et al.  TET-mediated active DNA demethylation: mechanism, function and beyond , 2017, Nature Reviews Genetics.

[23]  U. Bracale,et al.  Reply to Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up , 2016, ESMO Open.

[24]  Peter A. Jones,et al.  Epigenetic Determinants of Cancer. , 2016, Cold Spring Harbor perspectives in biology.

[25]  Jie Gu,et al.  Low level of 5-Hydroxymethylcytosine predicts poor prognosis in non-small cell lung cancer. , 2016, Oncology letters.

[26]  Pei-ling Li,et al.  5-Hydroxymethylcytosine expression is associated with poor survival in cervical squamous cell carcinoma. , 2016, Japanese journal of clinical oncology.

[27]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[28]  S. Nanjappa,et al.  Clostridium septicum Gas Gangrene in Colon Cancer: Importance of Early Diagnosis , 2015, Case reports in infectious diseases.

[29]  D. Gao,et al.  Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma , 2015, Tumor Biology.

[30]  S. Tsugane,et al.  Global methylation levels in peripheral blood leukocyte DNA by LUMA and breast cancer: a case–control study in Japanese women , 2014, British Journal of Cancer.

[31]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[32]  Fan Shen,et al.  Quantification of 5-methylcytosine and 5-hydroxymethylcytosine in genomic DNA from hepatocellular carcinoma tissues by capillary hydrophilic-interaction liquid chromatography/quadrupole TOF mass spectrometry. , 2013, Clinical chemistry.

[33]  B. Rosner,et al.  Pre-Diagnostic Leukocyte Genomic DNA Methylation and the Risk of Colorectal Cancer in Women , 2013, PloS one.

[34]  Thomas Rösch,et al.  Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer , 2013, Gut.

[35]  Z. Ling,et al.  Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation , 2013, Oncogene.

[36]  W. Nelson,et al.  Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma , 2012, PloS one.

[37]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[38]  Keji Zhao,et al.  Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. , 2011, Genes & development.

[39]  Bifeng Yuan.  5-methylcytosine and its derivatives. , 2014, Advances in clinical chemistry.

[40]  N. Matsubara.  Epigenetic regulation and colorectal cancer. , 2012, Diseases of the colon and rectum.